Dr Hickey is a teaching-research academic who leads the Synthesis of Biologically Active Molecules research group. His research lies at the interface of chemistry and biology and is particuarly interested in the lipid metabolic pathway and how its dysregulation is associated with several disease states. His research program is comprised of three main areas:
1) Develop new chemistry methodologies to synthesise biologically useful molecules with new functional group modifications.
2) Prepare novel organic and inorganic molecules suitable for live cellular imaging to better understand mechanisms which underpin disease and;
3) Design and synthesise new compounds that demonstrate anticancer, antimicrobial and antiviral... Read more
About me
Dr Hickey is a teaching-research academic who leads the Synthesis of Biologically Active Molecules research group. His research lies at the interface of chemistry and biology and is particuarly interested in the lipid metabolic pathway and how its dysregulation is associated with several disease states. His research program is comprised of three main areas:
1) Develop new chemistry methodologies to synthesise biologically useful molecules with new functional group modifications.
2) Prepare novel organic and inorganic molecules suitable for live cellular imaging to better understand mechanisms which underpin disease and;
3) Design and synthesise new compounds that demonstrate anticancer, antimicrobial and antiviral therapeutic potential.
To support his research program, Dr Hickey has partnered with collaborators from academia and industry, both nationally and internationally, that has resulted securing grant funding, publications, student supervisions and end-stage industry outcomes.
About me
Royal Australian Chemical Institute
American Chemical Society
Royal Chemical Society
Royal Society of Victoria
Golden Key Society
About me
Doctor of Philosophy Deakin University
Master of Teaching University of Adelaide
Bachelor of Forensic Science (Honours) Deakin University
Bachelor of Forensic Science Deakin University
Research
Excludes commercial-in-confidence projects.
Correlative Imaging of Brain Lipids., ARC - Discovery Projects, 01/01/2022 - 30/09/2025
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2022 |
Open access
71
57
1
|
| 2022 |
Open access
10
8
1
|
| 2021 |
11
11
9
|
| 2020 |
14
15
12
|
| 2018 |
Open access
24
24
|
| Year | Output |
|---|---|
| 2025 |
Open access
2
|
| 2024 |
Open access
1
|
| 2024 |
Open access
2
2
|
| 2024 |
Open access
2
2
|
| 2024 |
|
| 2024 |
Open access
7
7
|
| 2023 |
Open access
2
2
|
| 2023 |
9
9
|
| 2023 |
Open access
3
3
|
| 2023 |
Open access
3
3
1
|
| 2023 |
Open access
12
11
|
| 2023 |
Open access
9
8
122
|
| 2023 |
Open access
16
16
81
|
| 2023 |
Open access
6
6
9
|
| 2023 |
Open access
8
8
|
| 2022 |
Open access
5
5
|
| 2022 |
Open access
|
| 2022 |
Open access
1
1
|
| 2022 |
Open access
71
57
1
|
| 2022 |
Open access
10
8
1
|
| 2022 |
Open access
9
10
42
|
| 2022 |
Open access
4
5
1
|
| 2022 |
Open access
32
30
|
| 2021 |
13
12
1
|
| 2021 |
Open access
11
10
|
| 2021 |
11
11
9
|
| 2021 |
Open access
14
12
2
|
| 2020 |
Open access
64
52
2
|
| 2020 |
14
15
12
|
| 2019 |
Open access
96
94
1
|
| 2018 |
Open access
24
24
|
| 2017 |
12
12
3
|
| 2016 |
Open access
34
32
13
|
| 2015 |
11
11
1
|
| 2015 |
15
16
3
|
| 2015 |
Open access
14
16
|
| 2015 |
2
2
6
|
| 2015 |
Open access
3
3
|
| 2012 |
23
21
|
| 2012 |
11
11
|
External engagement & recognition
| Organisation | Country |
|---|---|
| Austin Health | AUSTRALIA |
| Australian National University | AUSTRALIA |
| Curtin University | AUSTRALIA |
| Deakin University | AUSTRALIA |
| Flinders Medical Centre | AUSTRALIA |
| Flinders University | AUSTRALIA |
| Malaghan Institute of Medical Research | NEW ZEALAND |
| Monash Institute of Pharmaceutical Science | AUSTRALIA |
| Monash University | AUSTRALIA |
| National Institutes of Health | MALAYSIA |
| RMIT University | AUSTRALIA |
| SA Pathology | AUSTRALIA |
| Shandong First Medical University | CHINA |
| Shandong University | CHINA |
| St. James's Hospital | UNITED STATES |
| The Coombe Hospital | IRELAND |
| Trinity College | AUSTRALIA |
| Trinity College Dublin | IRELAND |
| University of Adelaide | AUSTRALIA |
| University of Bologna | ITALY |
| University of Cambridge | UNITED KINGDOM |
| University of Dublin | IRELAND |
| University of Duisburg-Essen | GERMANY |
| University of Melbourne | AUSTRALIA |
| University of Queensland | AUSTRALIA |
| University of South Australia | AUSTRALIA |
| University of Sydney | AUSTRALIA |
| Walter and Eliza Hall Institute of Medical Research | AUSTRALIA |
External engagement & recognition
| Engagement/recognition | Year |
|---|---|
MemberRoyal Society of Chemistry (RSC) |
2020 |
MemberAmerican Chemical Society (ACS) |
2020 |
MemberRoyal Australian Chemical Institute (RACI) |
2020 |
MemberAmerican Chemical Society (ACS) |
2019 |
MemberRoyal Australian Chemical Institute (RACI) |
2019 |
MemberRoyal Society of Chemistry (RSC) |
2019 |
MemberRoyal Society of Chemistry (RSC) |
2018 |
MemberRoyal Society of Victoria (RSV) |
2018 |
MemberAmerican Chemical Society (ACS) |
2018 |
MemberRoyal Australian Chemical Institute (RACI) |
2018 |
MemberAmerican Chemical Society (ACS) |
2017 |
MemberRoyal Society of Chemistry (RSC) |
2017 |
MemberRoyal Australian Chemical Institute (RACI) |
2017 |
MemberAmerican Chemical Society (ACS) |
2016 |
MemberRoyal Society of Chemistry (RSC) |
2016 |
MemberRoyal Australian Chemical Institute (RACI) |
2016 |
MemberAmerican Chemical Society (ACS) |
2015 |
MemberRoyal Australian Chemical Institute (RACI) |
2015 |
MemberRoyal Society of Chemistry (RSC) |
2015 |
Teaching & student supervision
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| A fibre-optic system for real-time, in-vivo measurement of the metabolic status of tissues | Current |
| A SN38 antibody prodrug conjugate strategy for cancer therapy | Current |
| DECR1 Inhibition: a novel prostate cancer therapeutic strategy | Current |
| Defining critical changes in lipid metabolism during prostate cancer progression | Current |
| Developing advanced oral delivery systems for antiviral drugs | Current |
| Discovery of Cyclin-Dependent Kinase 6 (CDK6) small-molecule inhibitors and degraders for cancer therapy | Current |
| Targeting tankyrases for the treatment of cancer | Current |
| Coumarin amphiphiles as membrane-active antibacterial agents | Completed |
| Design, in silico assessment, and synthesis of quinoxaline platinum complexes as ATPase competitive topoisomerase inhibitors | Completed |
| Development and applications of metal ion complexes as live cellular imaging agents | Completed |
| Development of monoclonal antibody targeted therapeutics for prostate cancer | Completed |
| Liquid chromatography-tandem mass spectrometry-based bioanalysis to assess toxicological and therapeutic aspects in human disease conditions | Completed |
